298 filings
8-K
ACST
Acasti Pharma Inc.
25 Sep 24
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
8:00am
8-K
ACST
Acasti Pharma Inc.
16 Aug 24
Departure of Directors or Certain Officers
4:05pm
8-K
ACST
Acasti Pharma Inc.
9 Aug 24
Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
8:00am
8-K
ACST
Acasti Pharma Inc.
27 Jun 24
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
4:10pm
8-K
ACST
Acasti Pharma Inc.
21 Jun 24
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
8:00am
8-K
cz4n9xjascxvl63yug2
1 Apr 24
Regulation FD Disclosure
8:00am
8-K
5a6 m0mu3i5
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
8-K
bcqk5p3
8 Jan 24
Departure of Directors or Certain Officers
7:30am
8-K
jybetycs9l7jjms pj
15 Dec 23
Changes in Registrant's Certifying Accountant
7:30am
8-K
74fx08c30u c2ug
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
f5f8w5uhy7wn0wga
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
8-K
ht9lr p2os6
11 Oct 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
ia5r ctfeb1qayh5yc8a
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
8-K
ap5 qpc4q9iksen
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am
8-K
gskmc 71izibvc
24 Jul 23
Other Events
5:30pm
8-K
u5ctcwv6
7 Jul 23
Acasti Pharma Announces 1-for-6 Reverse Stock Split
8:30am
8-K
7auhi0 hftc
5 Jul 23
Other Events
4:00pm
8-K
kxe62j
23 Jun 23
Acasti Pharma Reports Fiscal Year 2023 Operational Results
7:31am
8-K
2wlr1ek d4ppq97
11 May 23
Departure of Directors or Certain Officers
4:50pm
8-K
gzlyaan7gcvt2 nc
5 Apr 23
Acasti Announces Appointment of Prashant Kohli as CEO
5:00pm